Rat Model Market Size & Growth

1. Global Rat Model Market Size - Forecasts to 2026 As per the research conducted by GME, the Global Rat Model Market will grow with a CAGR value of 8.6%. The rat model has numerous benefits over the mouse and other comparable creatures as a model of human illness. The expanding use of the mouse model not only in fundamental research but also in the applied sector of drug development and discovery is a major driver driving the global rat model market forward. Moreover, advancement in technology increased R&D activities will also fuel the market to rise during the predicted years. Browse 157 Market Data Tables and 117 Figures spread through 187 Pages and in-depth TOC on “Global Rat Model Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-rat-model-market-3148 By Type (Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned), By Technology (Nuclear transferase, Microinjection, Embryonic stem cell, Other), By Service (Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending, Others), By Application (Oncology, Neurology, Immunology, Toxicology, Others), By End-Use (CROs, Academic and research facility and Healthcare companies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End- User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights •The rat is an excellent model for heart disease, particularly stroke and hypertension. •The use of embryonic stem cell (ESC) technology in combination with insertional and chemical mutagenesis has expanded the range of rat models that can be used. •CRISPR technology (Other Technologies) is being more widely used in rat-based studies as the need for trained and genetically modified animals grows. •The increased frequency of disorders like Alzheimer's, stroke, and Parkinson's disease is predicted to make neurological disorders a profitable market for pharmaceutical companies. •Because of increased investments in biomedical research, greater awareness, and a flexible regulatory environment, the market in Latin America and the Rest of the World is expected to develop significantly. •GenOway, Charles River Laboratories International, Inc., Envigo, Covance Inc., Horizon Discovery Group plc, Janvier Labs, Taconic Biosciences, Inc., and Biomedical Research Models (Biomere) are the top players in the Rat Model Market. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-rat-model-market-3148

2. Type Outlook (Revenue, USD Million, 2021-2026) •Knockout •Outbred •Inbred •Hybrid •Immunodeficient •Conditioned Technology Outlook (Revenue, USD Million, 2021-2026) •Nuclear transferase •Microinjection •Embryonic stem cell •Other Service Outlook (Revenue, USD Million, 2021-2026) •Cryopreservation •Breeding •Rederivation •Genetic testing •Quarantine depending •Other Application Outlook (Revenue, USD Million, 2021-2026) •Oncology •Neurology •Immunology •Toxicology •Other End-Use Outlook (Revenue, USD Million, 2021-2026) •CROs •Academic and research facility •Healthcare companies Regional Outlook (Revenue, USD Million, 2021-2026)

3. North America •The U.S. •Canada •Mexico Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia Pacific •China •India •Japan •South Korea •Australia •Rest of APAC Central & South America •Brazil •Argentina •Rest of CSA Middle East & Africa •Saudi Arabia •UAE •Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com

4. Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php